These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 23645177

  • 21. Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials.
    Zangrillo A, Putzu A, Monaco F, Oriani A, Frau G, De Luca M, Di Tomasso N, Bignami E, Lomivorotov V, Likhvantsev V, Landoni G.
    J Crit Care; 2015 Oct; 30(5):908-13. PubMed ID: 26093802
    [Abstract] [Full Text] [Related]

  • 22. Levosimendan does not provide mortality benefit over dobutamine in adult patients with septic shock: A meta-analysis of randomized controlled trials.
    Bhattacharjee S, Soni KD, Maitra S, Baidya DK.
    J Clin Anesth; 2017 Jun; 39():67-72. PubMed ID: 28494911
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Levosimendan in cardiology and intensive care medicine].
    Delle Karth G, Heinz G.
    Wien Klin Wochenschr; 2004 Jan 31; 116(1-2):6-14. PubMed ID: 15030117
    [Abstract] [Full Text] [Related]

  • 28. Safety of Levosimendan in Pediatric Patients: An Up-to-Date Systematic Review.
    Pilia E, Silvetti S, Bohane SM, Pusceddu E, Belletti A, Collaborators.
    J Cardiothorac Vasc Anesth; 2024 Mar 31; 38(3):820-828. PubMed ID: 38135567
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.
    Duman D, Palit F, Simsek E, Bilgehan K, Sacide A.
    Can J Cardiol; 2009 Oct 31; 25(10):e353-6. PubMed ID: 19812809
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].
    Prijić S, Rakić S, Nikolić L, Jovicić B, Stajević M, Vukomanović V, Kosutić J.
    Vojnosanit Pregl; 2011 Nov 31; 68(11):979-84. PubMed ID: 22191317
    [Abstract] [Full Text] [Related]

  • 36. [Efficacy and safety of intravenous levosimendan compared with dobutamine in decompensated heart failure].
    Wang L, Cui L, Wei JP, Li GP, Qi GX, Hao YM, Wang WZ, Li HM, Liu J, Jiang DJ, Zhang YD.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun 31; 38(6):527-30. PubMed ID: 21033135
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT.
    Am J Cardiol; 2006 Jul 01; 98(1):102-6. PubMed ID: 16784930
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.